These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22093033)

  • 41. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Jiang HY; Wang SY; Deng M; Li YC; Ling ZX; Shao L; Ruan B
    Vaccine; 2017 May; 35(20):2633-2641. PubMed ID: 28404358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
    Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients.
    Lee JH; Hong S; Im JH; Lee JS; Baek JH; Kwon HY
    Vaccine; 2020 May; 38(24):3995-4000. PubMed ID: 32334887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review.
    Cordova E; Miglia I; Festuccia F; Sarlo MG; Scornavacca G; Punzo G; Menè P; Fofi C
    Ann Ig; 2017; 29(1):27-37. PubMed ID: 28067935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
    Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
    JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies].
    Fabrizi F; Messa P
    G Ital Nefrol; 2012; 29 Suppl 56():S78-84. PubMed ID: 23059944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies.
    Abd El-Wahab EW; Metwally M; Lotfy N
    Trop Med Int Health; 2021 Aug; 26(8):882-894. PubMed ID: 33860608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
    Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
    J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon.
    Halle MP; Choukem SP; Kaze FF; Ashuntantang G; Tchamago V; Mboue-Djieka Y; Temfack E; Luma HN
    Iran J Kidney Dis; 2016 Sep; 10(5):304-309. PubMed ID: 27721229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.
    Katoonizadeh A; Sharafkhah M; Ostovaneh MR; Norouzi A; Khoshbakht N; Mohamadkhani A; Eslami L; Gharravi A; Shayanrad A; Khoshnia M; Esmaili S; George J; Poustchi H; Malekzadeh R
    J Viral Hepat; 2016 Oct; 23(10):805-11. PubMed ID: 27126365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
    Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.